ATRISONE

Details for Australian Trade Mark No. 862834 (hide)

Owner Allergan Sales, LLC a Delaware USA Limited Liability company

Service Corrs Chambers Westgarth GPO Box 9925 SYDNEY NSW 2001 AUSTRALIA

Various Convention priority claimed: 14 July 2000, United States of America, No. 76/089169 in respect of PHARMACEUTICAL PREPARATIONS AND DRUG DELIVERY SYSTEM FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS.*

Classes

Class 5 Pharmaceutical preparations; pharmaceutical preparations being therapeutic products combining an active therapeutic ingredient or ingredients with a drug delivery system in the form of a substance providing either a timed or staged release of active ingredients or a vector for delivery of active therapeutic ingredients to either specific sites or across barriers ordinarily impervious to said therapeutic ingredients; pharmaceutical preparations being drug systems in this class as aforesaid

Event Publications

22 September 2005 Subsequent Owners/Holder Registered - Full Assignment

  Atrix Laboratories, Inc. a Delaware corporation is the full asignee of QLT USA, Inc..

20 November 2008 Subsequent Owners/Holder Registered - Full Assignment

  QLT USA, Inc. is the full asignee of Allergan, Inc a Delaware Corporation.

11 December 2008 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Allergan Sales, LLC a Delaware USA Limited Liability company.

4 August 2011 Trade Mark Removed from the Register / IR Expired

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

862835-SPOREVER

862833-LEUPROGEL